Department of Urology, Acibadem Maslak Hospital, Istanbul, Turkey.
Acibadem Maslak Hospital Assisted Reproductive Technologies Unit, Istanbul, Turkey.
J Obstet Gynaecol Res. 2024 Oct;50(10):1977-1984. doi: 10.1111/jog.16093. Epub 2024 Sep 20.
To assess the efficacy of intratesticular injection of autologous platelet-rich plasma (PRP) in men with non-obstructive azoospermia (NOA) and a history of failed microdissection-testicular sperm extraction (mTESE) procedures.
A prospective case series of a cohort study was conducted involving couples diagnosed with NOA. Patients with at least one failed mTESE procedure were included. Intratesticular PRP injection was performed using a standardized protocol. Follow-up assessments included sperm analysis, hormonal evaluation, and in vitro fertilization (IVF) outcomes.
Data from 177 men with NOA were analyzed, with 135 patients meeting eligibility criteria. PRP treatment resulted in positive sperm retrieval rates of 27.5% in patients with one prior failed mTESE procedure and 16.4% in patients with two or more failed attempts. IVF outcomes showed fertilization rates of 86.4% and 100.0% in respective groups, with pregnancy rates of 36.8% and 22.2% per embryo transfer. Histopathological examination post-mTESE revealed varied patterns, including Sertoli cell-only syndrome and maturation arrest.
Intratesticular PRP injection shows promise as a potential therapeutic approach for NOA patients with prior failed mTESE procedures, demonstrating improved sperm retrieval rates and favorable IVF outcomes. Further randomized controlled trials are warranted to validate these findings and refine the technique's efficacy in male infertility management to answer the question of whether PRP could significantly improve the second attempt retrieval rate.
评估自体富含血小板血浆(PRP)经睾丸内注射治疗非梗阻性无精子症(NOA)伴既往显微睾丸切开取精术(mTESE)失败患者的疗效。
对诊断为 NOA 的夫妇进行前瞻性病例系列队列研究。纳入至少有一次 mTESE 失败的患者。采用标准化方案进行经睾丸内 PRP 注射。随访评估包括精子分析、激素评估和体外受精(IVF)结局。
对 177 例 NOA 男性患者的数据进行了分析,其中 135 例符合入选标准。PRP 治疗后,一次 mTESE 失败的患者精子检出率为 27.5%,两次或以上失败的患者为 16.4%。IVF 结局显示,相应组的受精率分别为 86.4%和 100.0%,每个胚胎移植的妊娠率分别为 36.8%和 22.2%。mTESE 后组织病理学检查显示不同的模式,包括唯支持细胞综合征和成熟阻滞。
自体富含血小板血浆经睾丸内注射治疗既往 mTESE 失败的 NOA 患者具有一定的潜力,可提高精子检出率和 IVF 结局。需要进一步的随机对照试验来验证这些发现,并进一步明确该技术在男性不育管理中的疗效,以回答 PRP 是否能显著提高第二次尝试的检出率。